Yüklüyor......

Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment

SUMMARY: Gonadotropin-releasing hormone (GnRH) agonists, currently used in the treatment of advanced prostate cancer, have been described as a rare cause of pituitary apoplexy, a potentially life-threatening clinical condition. We report the case of a 69-year-old man with a known pituitary macroaden...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocrinol Diabetes Metab Case Rep
Asıl Yazarlar: Barbosa, Mariana, Paredes, Sílvia, Machado, Maria João, Almeida, Rui, Marques, Olinda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bioscientifica Ltd 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7354737/
https://ncbi.nlm.nih.gov/pubmed/32554827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-20-0018
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!